您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for treating patients with RTK mutant cells
专利权人:
Ignyta; Inc.
发明人:
Wei, Ge
申请号:
AU2016270321
公开号:
AU2016270321A1
申请日:
2016.05.25
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
Disclosed herein are compositions and methods for treating cancer patients who have been previously treated with one or more chemotherapeutic agents and have developed at least partial resistance to such chemotherapeutic agents. Also disclosed are methods for selecting compounds suitable for treatment of cancer in a patient who has become resistant to an inhibitor of a receptor tyrosine kinase (RTK).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充